Table 2.
Variables | The “most harmful” cases (N=395) | The “least harmful” cases (N=399) | p-value |
---|---|---|---|
Breast cancer grade | p<0.001 | ||
1 | 35 (8.86%) | 128 (32.08%) | |
2 | 128 (32.41%) | 118 (29.57%) | |
3 | 171 (43.29%) | 75 (18.80%) | |
4 | 1 (0.25%) | 0 (0%) | |
unknown | 60 (15.19%) | 78 (19.55%) | |
Regional nodes | p<0.001 | ||
negative | 111 (28.10%) | 201 (50.38%) | |
positive | 156 (39.49%) | 0 (0%) | |
unknown | 128 (32.41%) | 198 (49.62%) | |
Breast cancer stage | p<0.001 | ||
0 | 8 (2.02%) | 26 (6.51%) | |
I | 61 (15.44%) | 183 (45.86%) | |
II | 83 (21.01%) | 0 (0%) | |
III | 59 (14.94%) | 0 (0%) | |
IV | 19 (4.81%) | 0 (0%) | |
unknown | 165 (41.77%) | 190 (47.62%) | |
Tumor size | p<0.001 | ||
No mass | 3 (0.76%) | 0 (0%) | |
Small (<30 mm) | 186 (47.09%) | 292 (73.18%) | |
Large | 154 (38.99%) | 1 (0.25%) | |
unknown | 52 (13.16%) | 106 (26.57%) | |
ER | p<0.001 | ||
positive | 256 (64.81%) | 285 (71.43%) | |
negative | 85 (21.52%) | 1 (0.25%) | |
borderline | 5 (1.27%) | 2 (0.50%) | |
unknown | 49 (12.41%) | 111 (27.82%) | |
PR | p<0.001 | ||
positive | 169 (42.78%) | 250 (62.66%) | |
negative | 166 (42.03%) | 0 (0%) | |
borderline | 11 (2.78%) | 35 (8.77%) | |
unknown | 49 (12.41%) | 114 (28.57%) |